Subgroup Analysis: Efficacy and Safety of Panobinostat in Combination with SC Bortezomib and Oral Dexamethasone in Multiple Myeloma Patients with Lenalidomide-Refractory Disease
Joshua Richter, Jacob P. Laubach, Steve Stricker, Fredrik Schjesvold, David Cohan, Anna Sureda, Ewa Lech‐Marańda, Meral Beksaç, Vânia Hungria, Meletios A Dimopoulos, Ajai Chari, Paul G. Richardson, Philippe Moreau (2021). Subgroup Analysis: Efficacy and Safety of Panobinostat in Combination with SC Bortezomib and Oral Dexamethasone in Multiple Myeloma Patients with Lenalidomide-Refractory Disease. , 138(Supplement 1), DOI: https://doi.org/10.1182/blood-2021-153694.
